Dyadic International (NASDAQ:DYAI) Announces Earnings Results

Dyadic International (NASDAQ:DYAI) announced its earnings results on Tuesday. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.06, Zacks reports. Dyadic International had a negative return on equity of 149.16% and a negative net margin of 188.09%. The firm had revenue of $1.96 million during the quarter, compared to analyst estimates of $1.05 million. During the same period last year, the firm posted ($0.06) EPS.

Dyadic International Stock Performance

NASDAQ DYAI opened at $1.14 on Friday. The stock’s 50-day simple moving average is $1.13 and its two-hundred day simple moving average is $1.42. Dyadic International has a twelve month low of $0.93 and a twelve month high of $2.67. The company has a debt-to-equity ratio of 1.54, a quick ratio of 5.39 and a current ratio of 5.15.

Analyst Ratings Changes

Separately, HC Wainwright restated a “buy” rating and set a $6.00 price target on shares of Dyadic International in a research note on Thursday.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.